Cellular Metabolic Regulators
- 1 May 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 259 (5) , 999-1006
Abstract
The Toll like receptor 4 (TLR4) ligand endotoxin triggers robust systemic inflammatory responses in humans at doses > 1.0 ng/kg. In this study we tested the hypothesis that evidence of TLR4-induced responses would be detectable in leukocytes challenged with endotoxin doses that are below the threshold needed to trigger a characteristic systemic inflammatory phenotype in humans. Subjects were challenged with endotoxin at 1, 0.5, or 0.1 ng/kg (n=5 per dose). Systemic responses were monitored for 24 hour. Blood samples, collected at designated interval for up to 24 hours post-challenge, were used to determine plasma cytokines levels, total and differential leukocyte counts, expression of leukocyte cell surface receptors, and changes in the leukocyte transcriptome. Western blotting was used to determine changes in leukocyte protein expression. We found that in vivo endotoxin at concentrations <1.0 ng/kg triggers weak and variable responses in humans. In marked contrast, we show that endotoxin at a concentration as low as 0.1 ng/kg triggers a transient decline in cellular ATP levels in leukocytes. This is associated with the appearance of a unique protein expression signature in leukocytes. The protein expression signature includes three prominent features: i) AMP-activated protein kinase subunit α (AMPKα) degradation, ii) increased HIF-1α expression, and iii) autophagy, collectively indicative of a regulated metabolic response. An indistinguishable response phenotype was observed in human leukocytes treated with endotoxin in vitro. These data demonstrate for the first time in humans that a TLR4 ligand concentration that is below the threshold needed to trigger clinically evident systemic inflammatory manifestations initiates a transient decline in ATP levels, AMPKα degradation, HIF-1α expression, and autophagy in leukocytes. This establishes that low-grade TLR4 activation exerts control over leukocyte metabolism in the absence of systemic inflammatory indicators.Keywords
This publication has 51 references indexed in Scilit:
- A genomic storm in critically injured humansJournal of Experimental Medicine, 2011
- AMP-activated protein kinase—an energy sensor that regulates all aspects of cell functionGenes & Development, 2011
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolismNature Cell Biology, 2011
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1Nature Cell Biology, 2011
- Roles of SIRT1 in the Acute and Restorative Phases following Induction of InflammationJournal of Biological Chemistry, 2010
- In vivo endotoxin synchronizes and suppresses clock gene expression in human peripheral blood leukocytes*Critical Care Medicine, 2010
- NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1αNature, 2008
- Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to HypoxiaJournal of Biological Chemistry, 2008
- AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1αProceedings of the National Academy of Sciences of the United States of America, 2007
- LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processingThe EMBO Journal, 2000